[PDF][PDF] The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease

VL Gadd, R Skoien, EE Powell, KJ Fagan… - …, 2014 - Wiley Online Library
VL Gadd, R Skoien, EE Powell, KJ Fagan, C Winterford, L Horsfall, K Irvine, AD Clouston
Hepatology, 2014Wiley Online Library
Although nonalcoholic fatty liver disease (NAFLD) is conventionally assessed histologically
for lobular features of inflammation, development of portal fibrosis appears to be associated
with disease progression. We investigated the composition of the portal inflammatory
infiltrate and its relationship to the ductular reaction (DR), a second portal phenomenon
implicated in fibrogenesis. The portal inflammatory infiltrate may contribute directly to
fibrogenesis as well as influence the fate of the DR hepatic progenitor cells (HPCs) …
Although nonalcoholic fatty liver disease (NAFLD) is conventionally assessed histologically for lobular features of inflammation, development of portal fibrosis appears to be associated with disease progression. We investigated the composition of the portal inflammatory infiltrate and its relationship to the ductular reaction (DR), a second portal phenomenon implicated in fibrogenesis. The portal inflammatory infiltrate may contribute directly to fibrogenesis as well as influence the fate of the DR hepatic progenitor cells (HPCs), regulating the balance between liver repair and fibrosis. The presence of portal inflammation in NAFLD was strongly correlated with disease severity (fibrosis stage) and the DR. The portal infiltrate was characterized by immunostaining NAFLD liver biopsy sections (n = 33) for broad leukocyte subset markers (CD68, CD3, CD8, CD4, CD20, and neutrophil elastase) and selected inflammatory markers (matrix metalloproteinase 9 and interleukin [IL]‐17). Cells expressing all markers examined were identified throughout the liver lobules and in portal tracts, although portal tracts were more densely populated (P < 0.01), and dominated by CD68+ macrophages and CD8+ lymphocytes, at all stages of disease. An increase in portal macrophages in NAFLD patients with steatosis alone (P < 0.01) was the earliest change detected, even before elevated expression of the proinflammatory cytokines, IL1B and TNF, in patients with early NASH (P < 0.05). Portal and periductal accumulation of all other cell types examined occurred in progressed NASH (all P < 0.05). Conclusion: Knowledge of the complex cellular composition of the portal inflammatory infiltrate and HPC/DR niche in NAFLD will shape future functional studies to elucidate the contribution of portal inflammation to HPC differentiation and NAFLD pathogenesis. (Hepatology 2014;59:1393‐1405)
Wiley Online Library